Cabotegravir( S/GSK1265744 | GSK 744 | Cabotegravir )

Catalog No. M17126 CAS No. 1051375-10-0

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Group Booking Get Quotation Bulk Inquiry Add to Cart

Product Name

Cabotegravir
Note

Research use only, not for human use.
Brief Description

Cabotegravir (GSK744, GSK1265744) is a long-acting HIV integrase inhibitor and inhibits the HIV-1 integrase catalyzed strand transfer reaction (IC50: 3.0 nM).
Description

Cabotegravir, also known as S/GSK1265744 or GSK744, is potent HIV integrase inhibitor under development for the treatment of HIV infection. Cabotegravir has a carbamoyl pyridone structure similar to dolutegravir.
In Vitro

Cell Viability Assay Cell Line:MT-4 cells Concentration:0-32 nM Incubation Time:4 or 5 days Result:Showed antiviral activity with an EC50 of 1.3 nM.
In Vivo

——
Synonyms

S/GSK1265744 | GSK 744 | Cabotegravir
Pathway

Others
Target

Other Targets
Recptor

HIV integrase
Research Area

Infection
Indication

——

CAS Number

1051375-10-0
Formula Weight

405.35
Molecular Formula

C19H17F2N3O5
Purity

>98% (HPLC)
Solubility

DMSO : 12.67 mg/mL 31.26 mM;
SMILES

C[C@H]1CO[C@H]2N1C(=O)c1c(c(=O)c(cn1C2)C(=O)NCc1c(cc(cc1)F)F)O
Chemical Name

(3S,11aR)-N-(2,4-difluorobenzyl)-6-hydroxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide

1. Yoshinaga T, et al. Antimicrob Agents ChemOthers. 2015, 59(1), 397-406.

Calculator

molnova catalog